Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Insight into Cancer Vaccines

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Myc Mutations and Cancer

CDK9 and Cancer

Why are Cancer Cell Lines Useful?

What is the Tumor Microenvironment?

Cancer Pain Management

Microfluidic cancer treatment screen combined with flow cytometry

Cancer Epidemiology

Cancer Classification

See more featured articles »

Exploiting Enzymes in Cancer Diagnosis and Therapy

Cancer Symptoms

Acidosis and Tumor Progression

The Cancer Cell Surface Proteome as a Therapeutic Target

Cancer Diagnosis

Effects of Social and Economic Deprivation on Cancer Mortality

What is Merkel Cell Carcinoma?

Investigating the Molecular Mechanisms of Cancer

Is Cancer a Metabolic Disorder?

The Biochemistry of Breast Cancer Screening

Secondary Lung Cancer

Pediatric Cancer

Cured Meats, Nitrates, and Cancer Risk: Why Food Source and Processing Matter

What is Cancer?

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Cancer History

TARDIS: The Improved Method of Detecting Breast Cancer

Metastatic Migration in Cancer may be Influenced by Metabolism

The Effects of Cancer on Family Life

Cancer Screening Considerations: Balancing the Benefits and Risks

Insights into Oncofertility

Hypoxia Markers and Their Importance

British Pioneers in Cancer Biology

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Hot vs Cold: the differences between tumor types

Transforming Cancer Care through Genomic Testing

What is Immunochemotherapy?

Assay for Monitoring and Treating Malignant Brain Tumors

Cancer Prevention: Lowering your Risk

What Role do Biobanks Play in Cancer Research?

Overview of Cell Viability and Cytotoxicity

Cutaneous Manifestations of Internal Malignancy

Cancer Prognosis

Using Biomarkers to Detect Cancer

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Caring for a Loved One with Cancer

Targeted Cancer Therapies

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Cancer Pathophysiology

Secondary Brain Cancer

What Causes Cancer?

Cancer Research

What is Cancer of Unknown Primary?

What is Tumorigenesis?

Living with Cancer Pain

Cancer Pain

Extracellular Vesicles as Floating Cancer Biomarkers

Cancer Glossary

Cancer Management

Latest Cancer News and Research

Breast cancer co-opts the immune system to attract nerves that fuel tumor growth

New research from the University of Oklahoma demonstrates how an aggressive form of breast cancer co-opts the body's own immune system to attract nerves that fuel tumor growth.

4 Aug 2026

Malaria infection causes permanent damage to the spleen immune cells

Macrophages formed in the bone marrow can only assume the function of embryonal phagocytes, or "scavenger cells," to a certain degree according to a study by the University of Bonn and the Peter Doherty Institute for Infection and Immunity at the University of Melbourne.

4 Aug 2026

Latest hospital rankings place NYU Langone Health at the very top

NYU Langone Health continues to have the most No. 1-ranked specialties and the most top-10 ranked specialties among medical centers in the United States, according to the rankings released today by U.S. News & World Report.

4 Aug 2026

Insilico Medicine highlights AI-powered biological target discovery for rare sinonasal cancer

Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the publication of a collaborative study in the journal npj Precision Oncology.

4 Aug 2026

AI tool helps customize radiopharmaceutical therapy dosing

Radiopharmaceutical therapy (RPT) has made great strides over the last 50 years, having only recently received FDA approval to treat prostate cancer. But despite the progress-and billions of dollars of industry investments-one area that has lagged behind is dosing, which is still one-size-fits-all.

4 Aug 2026

New gum disease treatment kills harmful bacteria while saving beneficial microbes

Researchers at Nagoya University in Japan have created an innovative treatment for periodontitis that targets and eliminates harmful bacteria while preserving beneficial oral microbes essential for health.

4 Aug 2026

Cell village approach reveals genetic differences in cell fitness

How readily a cell divides and how well it survives is fundamental to life, shaping everything from organ size to the body's ability to withstand disease.

3 Aug 2026

Restricting select amino acids may mimic protein restriction’s healthy aging benefits

A review finds that restricting protein, particularly methionine, isoleucine, and valine, may improve metabolism and influence key aging pathways, largely in experimental models. Short human studies suggest metabolic benefits, but effects on lifespan remain unknown and restriction may harm people with unmet or increased protein needs.

3 Aug 2026

Current NICE criteria miss most younger women at breast cancer risk

The National Institute for Health and Care Excellence (NICE) criteria used to decide who should be referred by GPs for further breast cancer risk assessment and specialist care misses up to 95% of women under 50 who will go on to develop the disease in the next 10 years, new research by researchers at the University of Cambridge and The Institute of Cancer Research, London, has found.

3 Aug 2026

Two British birth cohorts find no added health burden from a coastal childhood

Researchers analyzing two British birth cohorts found no association between coastal residence in adolescence and midlife multimorbidity, while an unadjusted association in the 1958 cohort weakened after accounting for neighborhood deprivation.

3 Aug 2026

Advances in X chromosome inactivation open therapeutic opportunities for X-linked genetic disorders

A new review explores how advances in understanding X chromosome inactivation (XCI) are creating potential therapeutic opportunities for a range of X-linked genetic disorders, including Rett syndrome, Fabry disease, Duchenne muscular dystrophy, hemophilia, and others.

3 Aug 2026

UCLA researchers find strategy to improve prostate cancer therapies

UCLA researchers have identified a promising strategy to make a new class of targeted cancer therapies more effective against one of the deadliest forms of prostate cancer, potentially overcoming treatment resistance that has limited their success.

3 Aug 2026

Study of lung immune cells uncovers roots of autoimmune disease

A massive analysis of immune cells in human tissue is yielding clues to the root cause of lung and autoimmune diseases.

3 Aug 2026

Newly-discovered protein acts as off switch for human immune cells

Mayo Clinic researchers have identified a protein that cancer cells use to shut down the body's immune response, a discovery that could help scientists develop new treatments that make cancer immunotherapies more effective.

3 Aug 2026

RNA-based therapeutic strategy targets brain pathway behind cancer-associated cachexia

A new path has opened toward stopping cancer-associated cachexia, a devastating complication that gradually wastes patients away.

2 Aug 2026

Immune cell changes provide new insights into long COVID

Extreme fatigue, a racing pulse, shortness of breath, brain fog, aching joints-the symptoms of long COVID can vary widely, change unpredictably, and be difficult to even recognize as signs of the condition.

2 Aug 2026

AI-powered blood test detects liver cancer across distinct populations

Researchers at the Johns Hopkins Kimmel Cancer Center validated an artificial intelligence (AI)-powered blood test that accurately detected liver cancer in people from two geographically and biologically distinct populations and also uncovered the underlying biological signals that make the test effective.

31 Jul 2026

New discovery advances sustainable production of plant-based medicines

Two plants that cause neurotoxicity and paralysis in the tiniest doses are also known to counter pain, malaria, cancer and pests.

31 Jul 2026

Study offers a potential strategy to make nanoparticle-based cancer drugs more effective

A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to reshape the gut microbiome that can enhance the delivery of certain chemotherapies to tumors, offering a potential strategy to make nanoparticle-based cancer drugs more effective.

31 Jul 2026